Our data evidence the important roles of GPT2 and corresponding metabolism in airway epithelial cell dysfunction and chronic lung injury and indicate an alternative potential therapy for COPD by reprogramming glutamate‐dominated metabolisms. The gene discussed is GPT2; the disease is chronic obstructive pulmonary disease.